Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Bubs (ASX:BUB) share price rises on new Chinese deal

The Bubs Australia Ltd (ASX:BUB) share price is up after it announced a deal to maintain and grow its presence in the Chinese market.

The Bubs Australia Ltd (ASX: BUB) share price went up 5% after it announced a deal to maintain and grow its presence in the Chinese market.

Bubs is a growing infant formula business which specialises in goat milk products.

Bubs’ Chinese deal

Bubs has entered into binding agreements with Heilongjiang Ubeite Dairy Group Co Ltd (HUG) to secure an existing State Administration for Market Supervision (SAMR) approved goat infant formula brand slot and manufacture a new “ultra-premium” range of Bubs Chinese label formula products in China.

The application to renew the existing registration under Bubs’ brand with SAMR is now in progress and, if approved, the product launch is likely to commence in the second half of FY23.

Bubs said that the new “ultra-premium” Bubs Chinese label goat infant formula product range has been developed exclusively for Chinese infants, based on A2 goat milk protein and includes premium ingredients.

The Bubs China goat infant formula products have been formulated in accordance with its new standards. Once approved by SAMR, this will give Bubs access to the remaining 80% of China’s $40 billion infant formula market for the first time, while differentiating from Bubs’ English label products. This could be a boost for the Bubs share price.

In addition to the goat SAMR approved brand slot, HUG has granted Bubs a first right of refusal to secure a SAMR registered “ultra-premium” A2 protein cow milk slot for Bubs Supreme A2 protein brand. This is subject to Bubs meeting minimum volume commitments and targets for goat formula in year one.

A new Chinese company will be created for the purpose of operating a marketing and distribution joint venture, owned 75% of Bubs Australia and 25% by Zhitong.

Management comments

The Bubs Executive Chairman Dennis Lin said:

We have been closely observing China’s evolving infant formula market dynamics and the recent acquisitions of China’s infant formula manufacturing facilities by multiple multinational corporations operating in our sector. It is clear to us that China’s supply chain is coming of age, and this is being reflected in a segment of Chinese consumers gravitating towards a ‘China pride’ sentiment when choosing Chinese-made products.

He also pointed to the recent success that Bubs has experienced in the US by receiving FDA regulatory approval. This “really does put Bubs on the global map”.

Final thoughts on the Bubs share price

This is an interesting move by Bubs to try to capture more of the Chinese market. Shareholders will just have to hope that management have chosen the right structure and Chinese partners to be successful.

Bubs revenue has been rising, yet the Bubs share price is down 17% in the last month. I think it could be a high-risk, long-term opportunity. But, it will need to be successful at capturing meaningful market share in at least one of the USA or Chinese markets.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content